Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Extracellular Vesicles (EVs) & Nanoparticles 2024: Diagnostics, Delivery, Therapeutics

Heather Branscome's Biography



Heather Branscome, Senior Scientist, ATCC and Research Assistant, George Mason University

Heather Branscome is Senior Scientist at the American Type Culture Collection (ATCC). She is also affiliated with George Mason University as a Research Assistant. She has over 15 years of cross-functional experience working in cell and molecular biology to support various activities including product development, technology transfer, biomanufacturing, and quality control. In her current role she manages the Cell Biology Bioproduction and Preservation departments. She earned her MS in Cell and Molecular Biology from George Mason University and earned her PhD in Biosciences from George Mason University. Her primary research interests surround large-scale manufacturing of EVs and the functional analysis of stem cell EVs in the context of cellular repair.

Heather Branscome Image

Large Scale Manufacturing, Cargo Profiling, and Functional Effects of hTERT MSC EVs

Wednesday, 3 April 2024 at 13:30

Add to Calendar ▼2024-04-03 13:30:002024-04-03 14:30:00Europe/LondonLarge Scale Manufacturing, Cargo Profiling, and Functional Effects of hTERT MSC EVsExtracellular Vesicles (EVs) and Nanoparticles 2024: Diagnostics, Delivery, Therapeutics in Miami, FloridaMiami, FloridaSELECTBIOenquiries@selectbiosciences.com

Ocular diseases are a major cause of visual impairment and morbidity. Furthermore, exposure to ionizing radiation (IR) can cause direct damage to the eye. Therefore, there is an urgent need to explore novel ocular therapeutics. Extracellular Vesicles (EVs) from Mesenchymal Stem Cells (MSCs) have demonstrated widespread regenerative properties across multiple pathologies. However, the reparative effects of MSC EVs against ocular damage remains relatively unexplored. Here, we report a large-scale platform for manufacturing of EVs from hTERT-immortalized MSCs and evaluate their reparative properties on retinal cells before and after exposure to IR. Additionally, we evaluate the efficacy of a novel EV lyophilization buffer for improved EV storage, transport, and stability. Physical and biochemical properties of EVs were assayed using various techniques including NTA, western blot, mass spectrometry, RNAseq, and multiplex immunoassays. EV functionality was evaluated in vitro using a combination of assays to assess cell viability, cell migration, cell cycle, and apoptosis before and after exposure to IR. Collectively, our data suggests that hTERT MSC EVs are enriched with unique cargos and that these EVs exert reparative properties on retinal cells in vitro against irradiation-induced damage. Importantly, lyophilization of EVs further extended their shelf life without impacting their function.


Add to Calendar ▼2024-04-03 00:00:002024-04-04 00:00:00Europe/LondonExtracellular Vesicles (EVs) and Nanoparticles 2024: Diagnostics, Delivery, TherapeuticsExtracellular Vesicles (EVs) and Nanoparticles 2024: Diagnostics, Delivery, Therapeutics in Miami, FloridaMiami, FloridaSELECTBIOenquiries@selectbiosciences.com